Ascletis Pharma Inc. (OTCMKTS:ASCLF – Get Free Report) rose 4.8% on Wednesday. The company traded as high as $1.09 and last traded at $1.09. Approximately 275 shares changed hands during mid-day trading, a decline of 90% from the average daily volume of 2,638 shares. The stock had previously closed at $1.04.
Ascletis Pharma Trading Up 4.8%
The business has a 50-day moving average of $1.21 and a 200-day moving average of $1.53.
Ascletis Pharma Company Profile
Ascletis Pharma Inc is a biopharmaceutical company focused on the discovery, development and commercialization of innovative medicines. The company has historically concentrated on areas of significant unmet medical need, including viral diseases, oncology and metabolic disorders, with operations and commercial activities centered primarily in China.
Ascletis’ portfolio has included therapies for infectious diseases and viral hepatitis. Its best-known product is Ganovo (danoprevir), a hepatitis C treatment developed for use in combination with other antiviral medicines and approved in China.
Featured Articles
- Five stocks we like better than Ascletis Pharma
- Skydance Just Became a Media Giant—With an $80 Billion Debt Load
- Could Velo3D Be the Next Defense Buyout Target?
- Penguin Solutions Is Soaring as AI Memory Demand Explodes
- Alphabet’s Chart Is Coiling—and the Fundamentals May Be Ready to Back It Up
Receive News & Ratings for Ascletis Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ascletis Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
